CoChat

Compact automated culture machine for human induced pluripotent stem cell maintenance and differentiation

Open access
Bando, Kazunori, Yamashita, Hiromi, Tsumori, Motomu, Minoura, Hayase, Okumura, Koji, Hattori, Fumiyuki · 2022 · Frontiers in Bioengineering and Biotechnology

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

The technologies used to generate human induced pluripotent stem cell (iPSC) from somatic cells potentially enable the wide application of iPSC-derived differentiated cells in industrial research fields as a replacement for animals. However, as highly trained individuals are required to obtain reproducible results, this approach has limited social implementation. In the research field of iPSC, it is believed that documentable information is not enough for reproducing the quality of the differentiated cells. Therefore, automated culture machines for cell processing should make the starting of iPSC-using researches easier. We developed a programmable all-in-one automated culture machine, with dense and compact constitution that fits within a normal biosafety cabinet (200 mm wide, 233 mm height, and 110 mm depth). This instrument was fabricated using novel x-y-z-axes-rail-system, such as an overhead traveling crane, in a factory, which served as the main handling machinery. This machine enabled stable and efficient expansion of human iPSC under the feeder-free condition, without karyotype alterations, and simultaneously differentiated the cells into various cell types, including cardiomyocytes, hepatocytes, neural progenitors, and keratinocytes. Overall, this machine would facilitate the social implementation of human pluripotent stem cells and contribute to the accumulation of sharable knowledge for the standardization of the entire handling processes of iPSC in pharmaceutical, food, and cosmetic research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2022.1074990

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Summary of the automated culture machine. (A) Image of the whole machine and its size. (B) Schematic of the machine. (C) Close view of the x-y-z-axes-rail-system. (D) Loading of the trypan blue-stained cells into the cell counting plate.
FIGURE 1 Summary of the automated culture machine. (A) Image of the whole machine and its size. (B) Schematic of the machine. (C) Close view of the x-y-z-axes-rail-system. (D) Loading of the trypan blue-stained cells into the cell counting plate.CC BY · PubMed Central
FIGURE 2 Passage task and cell growth. (A) The square illustrates each process. (B) Representative images captured automatically from passage to passage. Each inset indicates enlarged image. Scale bars, 400 μm (B); and 100 μm (inset B).
FIGURE 2 Passage task and cell growth. (A) The square illustrates each process. (B) Representative images captured automatically from passage to passage. Each inset indicates enlarged image. Scale bars, 400 μm (B); and 100 μm (inset B).CC BY · PubMed Central
FIGURE 3 Automated long-term maintenance of iPSC. (A) All immunocytometorical analyses of the three independent experiments for Oct-3/4 and SSEA-4. Each blue histogram indicates no primary antibody control. Each red histogram represents the indicated antigen-specific signal. (B) iPSC expansion calculated using every automated cell count in the three independent experiments. (C) Representative images of immunohistochemically stained cells for Oct-3/4, SSEA-4, and Tra 1–61. Scale bars = 50 μm. (D) Karyotype of the RIKEN2F-iPSC after the fifth passage.
FIGURE 3 Automated long-term maintenance of iPSC. (A) All immunocytometorical analyses of the three independent experiments for Oct-3/4 and SSEA-4. Each blue histogram indicates no primary antibody control. Each red histogram represents the indicated antigen-specific signal. (B) iPSC expansion calculated using every automated cell count in the three independent experiments. (C) Representative images of immunohistochemically stained cells for Oct-3/4, SSEA-4, and Tra 1–61. Scale bars = 50 μm. (D) Karyotype of the RIKEN2F-iPSC after the fifth passage.CC BY · PubMed Central
FIGURE 4 Cardiomyogenic differentiation using human iPSC (KMUR001). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast micrography. Scale bar = 200 μm. (C) Immunohistochemical staining for Troponin T (TnT): green, and Actinin: red. The nucleus was stained with DAPI. Scale bar = 100 μm.
FIGURE 4 Cardiomyogenic differentiation using human iPSC (KMUR001). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast micrography. Scale bar = 200 μm. (C) Immunohistochemical staining for Troponin T (TnT): green, and Actinin: red. The nucleus was stained with DAPI. Scale bar = 100 μm.CC BY · PubMed Central
FIGURE 5 Hepatocyte differentiation using the human iPSC (RIKEN2F). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast micrography. Scale bar = 100 μm. (C) Immunohistochemical staining for Albumin: green, and hepatocyte nuclear factor 4 alpha (HNF-4A): red. The nucleus was stained with DAPI. Scale bar = 100 μm.
FIGURE 5 Hepatocyte differentiation using the human iPSC (RIKEN2F). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast micrography. Scale bar = 100 μm. (C) Immunohistochemical staining for Albumin: green, and hepatocyte nuclear factor 4 alpha (HNF-4A): red. The nucleus was stained with DAPI. Scale bar = 100 μm.CC BY · PubMed Central
FIGURE 6 Neuronal progenitor cell differentiation using the human iPSC (RIKEN2F). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast microscopy. Scale bar = 100 μm. (C) Immunohistochemical staining for Nestin: green. The nucleus was stained with DAPI. Scale bar = 200 μm. (D) Continuous culture confirmed the neuronal differentiation of the progenitor cells. Immunohistochemical staining for ßIII Tubulin: green, and Neurofilament M: red. The nucleus was stained with DAPI. Scale bar = 100 μm.
FIGURE 6 Neuronal progenitor cell differentiation using the human iPSC (RIKEN2F). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast microscopy. Scale bar = 100 μm. (C) Immunohistochemical staining for Nestin: green. The nucleus was stained with DAPI. Scale bar = 200 μm. (D) Continuous culture confirmed the neuronal differentiation of the progenitor cells. Immunohistochemical staining for ßIII Tubulin: green, and Neurofilament M: red. The nucleus was stained with DAPI. Scale bar = 100 μm.CC BY · PubMed Central
FIGURE 7 Keratinocyte differentiation using the human iPSC (253G1). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast micrography. Scale bar = 200 μm. (C) Immunohistochemical staining for Keratin-1: green, and Keratin-10: red. The nucleus was stained with DAPI. Scale bar = 200 μm.
FIGURE 7 Keratinocyte differentiation using the human iPSC (253G1). (A) Schedule of the combination of processes including passage and differentiation. (B) Step by step changes in the cell figures based on phase contrast micrography. Scale bar = 200 μm. (C) Immunohistochemical staining for Keratin-1: green, and Keratin-10: red. The nucleus was stained with DAPI. Scale bar = 200 μm.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 8

Metadata

Authors
Bando, K., Yamashita, H., Tsumori, M., Minoura, H., Okumura, K., & Hattori, F.
Affiliations
  • Kansai Medical University (JP)
  • Panasonic (Japan) (JP)
Corresponding author
Hattori, Fumiyuki
Venue
Frontiers in Bioengineering and Biotechnology
Published
2022-11-29
Volume
10
Pages
1074990-1074990
ISSN
2296-4185 (ISSN-L)
OpenAlex
W4310192096
Cited by
8
References
10
Citations by year
2026: 3 · 2025: 1 · 2024: 1 · 2023: 3
FWCI
0.41
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
human induced pluripotent stem cells, iPSC differentiation, feeder-free culture, karyotype stability, cardiomyocytes, hepatocytes, neural progenitor cells, keratinocytes, biological safety cabinet, reproducibility

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.